Amiodarone is an important treatment for supraventricular and ventricular arrhythmias, with an emerging role in improving outcomes for patients at high risk for arrhythmic events and sudden death.
Provides practical guidelines for the clinical use of amiodarone in the management of supraventricular and ventricular arrhythmias.
Absolute Event Rate: 0% vs 0%
Amiodarone has become an important drug for the treatment of supraventricular and ventricular arrhythmias, in short-term inpatient and outpatient settings. It may also have a role in affecting outcome in patients at high risk for arrhythmic events and sudden death; its place among available therapies is being established in clinical trials.
Nora Goldschlager (Mon,) reported a other. Amiodarone is an important treatment for supraventricular and ventricular arrhythmias, with an emerging role in improving outcomes for patients at high risk for arrhythmic events and sudden death.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: